SOURCES SOUGHT
70 -- TheraDoc Software product or comparable solutions
- Notice Date
- 6/22/2020 8:34:55 AM
- Notice Type
- Sources Sought
- NAICS
- 541519
— Other Computer Related Services
- Contracting Office
- TECHNOLOGY ACQUISITION CENTER AUSTIN (36C10A) AUSTIN TX 78744 USA
- ZIP Code
- 78744
- Solicitation Number
- 36C10A20Q0205
- Response Due
- 6/29/2020 12:00:00 PM
- Archive Date
- 07/14/2020
- Point of Contact
- Technology Acquisition Center-Austin, Juan C. Perez, Phone: 512-981-4467
- E-Mail Address
-
Juan.Perez5@va.gov
(Juan.Perez5@va.gov)
- Awardee
- null
- Description
- RFI Notice The Department of Veterans Affairs is conducting market research for TheraDoc Software product or comparable solutions. This notice is issued solely for information and planning purposes - it does not constitute a Request for Quote (RFQ)/Invitation for Bid (IFB)/Request for Proposal (RFP) or a promise to issue an RFQ, IFB or RFP in the future. This notice does not commit the VA to contract for any supply or service. Further, the VA is not seeking quotes, bids or proposals at this time and will not accept unsolicited proposals in response to this RFI notice. The VA will not pay for any information or administrative costs incurred in response to this notice. Submittals will not be returned to the responder. Not responding to this notice does not preclude participation in any future RFQ or IFB or RFP, if any is issued. It is the responsibility of potential offerors to monitor the Governmentwide Point of Entry for additional information pertaining to this requirement. The anticipated NAICS code is: 541519 Other Computer related services A brief synopsis of the required services is provided below: VA is seeking information on patient monitoring software that meets the salient characteristics listed below. If interested and capable of providing an equal product, please see How to respond instructions below to submit proposals/ response or questions if Applicable. The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Pharmacy Service at the Louis Stokes Cleveland VA Medical Center currently uses TheraDoc patient monitoring software solution. The TheraDoc software solution provides clinical staff immediate real-time lists of patients, identifies those patients who need clinical intervention, and provides the ability to monitor and protect patients from drug interactions and adverse events. The current contract expires in November 2020, and VA is seeking information on similar products that may meet its needs for future contracts. VA Minimum Requirement/Salient Characteristics Software solution should include clinical surveillance that can be customized for & by users within section cohorts (i.e., Antimicrobial Stewardship/ID, Internal Medicine, Infection Prevention) via alert panels stratified by clinical section, alert type, date/time range, unit/hospital/outpatient location, etc. Critical deliverables for clinical surveillance include, but are not limited to, the following: Customizable alerts (e.g., broad-spectrum de-escalation after 48 hours, drug-bug mismatch, positive cultures, penicillin allergy panel, renal dosing/acute kidney injury predictive analytics, febrile neutropenia, anticoagulation, notifiable disease, and patient contact tracing); Clinical rounding panel(s) that satisfy Bates s Commandments for Clinical Decision Support with pre-fetched, single-page display of active antimicrobial orders, medication administration record, vitals (with minimum and maximum values), labs, therapeutic drug monitoring, radiology, microbiology, pathology, antipyretics, and immunosuppressants for current and past admissions; and CLSI-concordant antibiograms for Gram-positive, Gram-negative, and antifungal agents from May 2018 and carried forward Critical reporting function should include customizable reports for intervention tracking by user to calculate intervention acceptance rates, automatic calculation of antimicrobial days/1000 days present by agent and hospital location, and selected infection rates (i.e., MRSA, C. difficile, COVID-19, influenza, legionella, etc.). Reference: Bates DW, Kuperman GJ, Wang S, et al. Ten commandments for effective clinical decision support: making the practice of evidence-based medicine a reality. J Am Med Inform Assoc. 2003;10(6):523-30. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC264429/#__sec2title Additional Product Information: Do you have the capability to customize EHR interfacing via interpretation of programmatic uniqueness for a given VistA instance? Can you guarantee that an interface with VA VistA/CPRS is accurate? How much time is needed for data validation by site clinical experts during implementation? Can you retrieve 3 years of data from a competitor database and incorporate this historical data into a new database that is compatible with your software? How would this be accomplished specifically? How much time from the date of award of a new contract would be required for VA to have full access to your product, including ATO, transition of existing database data, etc.? Is there an onsite clinical specialist (preferably a pharmacist) on your team that can work to customize, train, and work with clinical staff regarding the software? Questions from Antimicrobial Stewardship perspective: Can ad hoc alerts be created and/or imported from other VA facilities currently using your software solution? Can your software solution coordinate Health Level 7 messaging standards with myriad terminology standards (i.e., Logical Observation Identifiers Names and Codes [LOINC], Digital Imaging and Communications in Medicine [DICOM], RxNorm, etc.), Bar Code Medication Administration (BCMA), and vitals disparate data from VistA into a single-page graphical user interface for daily patient rounds? What is the intervention tracking system in place for monitoring activity and cost savings (i.e., pending, completed, accepted, rejected, etc.)? If available, can data be drilled down by clinical intervention, user, and date range for downloadable reports? If available, can raw data be exported to external analytic software (i.e., Excel, PowerBI)? How robust/intelligent are your antimicrobial and microorganism databases to prevent false-positive Drug-Bug mismatch alerts (especially with MALDI-TOF identification of obscure organisms)? Do you have functioning antimicrobial stewardship software solutions with other VA facilities ? If so, please list specific affiliations with VA sites. How do you communicate with VistA to automatically obtain bed days of care data by unit for AU metric calculations (i.e., antimicrobial days/1000 days present) and reporting to CDC s National Health and Safety Network (NHSN)? How do you calculate susceptibility rates for antibiogram creation in your software solution? How can you operationalize surveillance of inpatients with penicillin allergies who are currently receiving antimicrobials? If so, can this be duplicated for facility outpatients? How can you operationalize reports for positive, negative, or range-specific diagnostic test results within a cohort of patients who received a specific medication? Questions from Infection Prevention perspective: How can you operationalize surveillance of inpatients with influenza, MRSA, C. difficile, Legionella infection, notifiable diseases, and COVID-19? What capability do you have for inpatient contact tracing? How to Respond: Responses should be as complete and informative as possible. It is requested that interested offerors respond to the following questions: Provide a brief summary of your technical capability to meet the requirements, to include specific product information. Please directly address each of the technical questions or reference a section in your technical capability statement that provides additional information If you believe any of the requirements are too restrictive/unnecessary, please explain in detail. Please provide any questions/comments/recommendations on the salient characteristics or provide any information that may VA better define this requirement. Please provide any existing contract vehicles (GSA FSS, GWAC, etc) you currently hold for which this requirement would be within scope. Is your company the OEM of the product or a reseller? If an OEM, do you have resellers available? Name of the firm, point of contact, phone number, email address, DUNS number, CAGE code, a statement regarding small business status (including small business type (s)/certifications(s) such as SDB, 8(a), HUBZone, SDVOSB, WOSB, etc.) under the corresponding NAICS code. RESPONSE SUBMISSION Please submit responses via email to Juan.Perez5@va.gov by 2:00 PM EST, June 29, 2020. VA reserves the right not to respond to any or all emails or materials submitted.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/e8b2e8d9e09f45f0ac35e224473dac1c/view)
- Record
- SN05699404-F 20200624/200623042720 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |